Literature DB >> 28062577

Overlapping Specificity of Duplicated Human Pancreatic Elastase 3 Isoforms and Archetypal Porcine Elastase 1 Provides Clues to Evolution of Digestive Enzymes.

Eszter Boros1,2, András Szabó2, Katalin Zboray1, Dávid Héja1, Gábor Pál3, Miklós Sahin-Tóth4,5.   

Abstract

Chymotrypsin-like elastases (CELAs) are pancreatic serine proteinases that digest dietary proteins. CELAs are typically expressed in multiple isoforms that can vary among different species. The human pancreas does not express CELA1 but secretes two CELA3 isoforms, CELA3A and CELA3B. The reasons for the CELA3 duplication and the substrate preferences of the duplicated isoforms are unclear. Here, we tested whether CELA3A and CELA3B evolved unique substrate specificities to compensate for the loss of CELA1. We constructed a phage library displaying variants of the substrate-like Schistocerca gregaria proteinase inhibitor 2 (SGPI-2) to select reversible high affinity inhibitors of human CELA3A, CELA3B, and porcine CELA1. Based on the reactive loop sequences of the phage display-selected inhibitors, we recombinantly expressed and purified 12 SGPI-2 variants and determined their binding affinities. We found that the primary specificity of CELA3A, CELA3B, and CELA1 was similar; all preferred aliphatic side chains at the so-called P1 position, the amino acid residue located directly N-terminal to the scissile peptide bond. P1 Met was an interesting exception that was preferred by CELA1 but weakly recognized by the CELA3 isoforms. The extended substrate specificity of CELA3A and CELA3B was comparable, whereas CELA1 exhibited unique interactions at several subsites. These observations indicated that the CELA1 and CELA3 paralogs have some different but also overlapping specificities and that the duplicated CELA3A and CELA3B isoforms did not evolve distinct substrate preferences. Thus, increased gene dosage rather than specificity divergence of the CELA3 isoforms may compensate for the loss of CELA1 digestive activity in the human pancreas.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  chymotrypsin; chymotrypsin C; elastase; pancreas; phage display; protease inhibitor; serine protease

Mesh:

Substances:

Year:  2017        PMID: 28062577      PMCID: PMC5314167          DOI: 10.1074/jbc.M116.770560

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans.

Authors:  Edit Szepessy; Miklós Sahin-Tóth
Journal:  Pancreatology       Date:  2005-12-01       Impact factor: 3.996

2.  Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin.

Authors:  T Komiyama; R S Fuller
Journal:  Biochemistry       Date:  2000-12-12       Impact factor: 3.162

3.  Characterization of a silent gene for human pancreatic elastase I: structure of the 5'-flanking region.

Authors:  T Tani; I Kawashima; H Furukawa; T Ohmine; Y Takiguchi
Journal:  J Biochem       Date:  1987-03       Impact factor: 3.387

4.  The action of elastase on p-nitroanilide substrates.

Authors:  J Bieth; C G Wermuth
Journal:  Biochem Biophys Res Commun       Date:  1973-07-17       Impact factor: 3.575

5.  Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones.

Authors:  J C Powers; B F Gupton; A D Harley; N Nishino; R J Whitley
Journal:  Biochim Biophys Acta       Date:  1977-11-23

6.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

7.  Electrophoretic characterization of porcine pancreatic (pro)elastases A and B.

Authors:  M Ledoux; F Lamy
Journal:  Can J Biochem       Date:  1975-04

8.  A novel proteinase from human pancreas.

Authors:  A Sziegoleit
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

9.  When the surface tells what lies beneath: combinatorial phage-display mutagenesis reveals complex networks of surface-core interactions in the pacifastin protease inhibitor family.

Authors:  Borbála Szenthe; András Patthy; Zoltán Gáspári; Adrienna Katalin Kékesi; László Gráf; Gábor Pál
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

10.  High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfide-rich proteins in E. coli.

Authors:  Hervé Nozach; Carole Fruchart-Gaillard; François Fenaille; Fabrice Beau; Oscar Henrique Pereira Ramos; Badreddine Douzi; Natalie J Saez; Mireille Moutiez; Denis Servent; Muriel Gondry; Robert Thaï; Philippe Cuniasse; Renaud Vincentelli; Vincent Dive
Journal:  Microb Cell Fact       Date:  2013-04-22       Impact factor: 5.328

View more
  4 in total

1.  Detection of human elastase isoforms by the ScheBo Pancreatic Elastase 1 Test.

Authors:  Anna Zsófia Tóth; András Szabó; Eszter Hegyi; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-03-30       Impact factor: 4.052

2.  Loss-of-function variant in chymotrypsin like elastase 3B (CELA3B) is associated with non-alcoholic chronic pancreatitis.

Authors:  Andrea Tóth; Alexandra Demcsák; Florence Zankl; Grzegorz Oracz; Lara Sophie Unger; Peter Bugert; Helmut Laumen; Andrea Párniczky; Péter Hegyi; Jonas Rosendahl; Tomasz Gambin; Rafał Płoski; Dorota Koziel; Stanisław Gluszek; Fredrik Lindgren; J Matthias Löhr; Miklós Sahin-Tóth; Heiko Witt; Agnieszka Magdalena Rygiel; Maren Ewers; Eszter Hegyi
Journal:  Pancreatology       Date:  2022-06-23       Impact factor: 3.977

3.  Arg236 in human chymotrypsin B2 (CTRB2) is a key determinant of high enzyme activity, trypsinogen degradation capacity, and protection against pancreatitis.

Authors:  Bálint Zoltán Németh; Alexandra Demcsák; András Micsonai; Bence Kiss; Gitta Schlosser; Andrea Geisz; Eszter Hegyi; Miklós Sahin-Tóth; Gábor Pál
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2022-08-05       Impact factor: 4.125

4.  Directed Evolution-Driven Increase of Structural Plasticity Is a Prerequisite for Binding the Complement Lectin Pathway Blocking MASP-Inhibitor Peptides.

Authors:  Zsolt Dürvanger; Eszter Boros; Zoltán Attila Nagy; Rózsa Hegedüs; Márton Megyeri; József Dobó; Péter Gál; Gitta Schlosser; Annamária F Ángyán; Zoltán Gáspári; András Perczel; Veronika Harmat; Gábor Mező; Dóra K Menyhárd; Gábor Pál
Journal:  ACS Chem Biol       Date:  2022-04-04       Impact factor: 4.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.